Search

Contributor:

Karl Csaky, MD, PhD

AAO Late Breaker: Ang-2 Mediation in DME Therapy

ASRS 2021: ARCHWAY and TENAYA/LUCERNE

Novel C5 Inhibitor for GA Growth

Novel C5 Inhibitor for GA Growth

Karl Csaky, MD, PhD

Variable Segmentation on Eyes With CNV with SPECTRALIS

Variable Segmentation on Eyes With CNV with SPECTRALIS

Karl Csaky, MD, PhD; Steve Thomas, CRA

SPECTRALIS Q&A: Part 1

SPECTRALIS Q&A: Part 1

Karl Csaky, MD, PhD; Steve Thomas, CRA; Chris Wong

Enhanced Segmentation of OCTA Images with SPECTRALIS

Enhanced Segmentation of OCTA Images with SPECTRALIS

Karl Csaky, MD, PhD; Steve Thomas, CRA

SPECTRALIS Q&A: Part 2

SPECTRALIS Q&A: Part 2

Karl Csaky, MD, PhD; Steve Thomas, CRA; Chris Wong

Expand Your Analysis of Abnormalities and Tissue Loss with SPECTRALIS

Expand Your Analysis of Abnormalities and Tissue Loss with SPECTRALIS

Karl Csaky, MD, PhD; Steve Thomas, CRA

Easily Follow Patient Progression Utilizing Tools Available Within SPECTRALIS

Easily Follow Patient Progression Utilizing Tools Available Within SPECTRALIS

Karl Csaky, MD, PhD; Steve Thomas, CRA

AAO Late Breaker: Ang-2 Mediation in DME Therapy

Karl Csaky, MD, PhD

AAO ’23: Real-World Faricimab Patterns and Improving GA Assessments

Sophie Bakri, MD; and Karl Csaky, MD, PhD

ASRS 2021 Coverage: ARCHWAY and TENAYA/LUCERNE

Chirag Jhaveri, MD; and Karl Csaky, MD